DCEG News Updates
The latest news and research findings from the Division of Cancer Epidemiology and Genetics.
-
Aspirin Use Associated with Increased Survival in Biliary Tract Cancer
Study finds aspirin use is associated with increased survival in biliary tract cancer patients.
-
New Reports Highlight the Critical Role of Physical Activity for Cancer Prevention, Treatment, and Survival
Roundtable on Exercise and Cancer updates the evidence on physical activity for the prevention of multiple cancer types, and the importance of exercise for cancer patients and survivors to improve their physical and psychological health.
-
HPV Vaccine May Provide Men with Herd Immunity against Oral HPV Infections
Oral HPV infections among unvaccinated men dropped 37% in 2009-2016 which may be a result of herd immunity by the HPV vaccine.
-
Weinberg Delivers 2019 Wacholder Lecture
Clarice Weinberg delivered the 2019 Sholom Wacholder Distinguished Lecture on Evidence for Familial Clustering of Breast Cancer Age at Onset.
-
Borrego and Davis Lynn Become Independent Research Scholars
David Borrego and Brittny Davis Lynn were inducted into the inaugural cohort of the Independent Research Scholar Program in the NIH Office of Intramural Research in August 2019.
-
Catherine Schairer Retires from DCEG
Catherine Schairer, Ph.D., M.S., senior staff scientist in the Metabolic Epidemiology Branch, retired from DCEG in September 2019, after 37 years of service.
-
Sir John Burn Delivers Seminar on Prediction and Prevention of Colorectal Cancer in Patients with Lynch Syndrome
In July 2019, Sir John Burn spent two days with DCEG staff and fellows as a Visiting Scholar during which time he delivered an informative seminar on prediction and prevention of colorectal cancer in patients with Lynch Syndrome.
-
Scientific Highlights July - October 2019
Selected scientific papers published by DCEG scientists July - October 2019
-
Trabert Granted DoD Investigator-Initiated Research Award
Britton Trabert received a Department of Defense Investigator-Initiated Research Award for her proposal titled “Making the CASE: Chemopreventive use of ASpirin for ovarian cancer—integrating Epidemiological data to evaluate population subgroups and tumor expression.”
-
2019 Camp Fantastic
In August 2019, DCEG staff and fellows spent a week in the Shenandoah Valley, Virginia, volunteering at Camp Fantastic, a summer camp for children affected by cancer.
-
Summer Intern on Volunteering at Camp Fantastic
Frank Colon-Matos, a summer intern in DCEG, shares his experience at Camp Fantastic 2019 as a childhood cancer survivor and first-time volunteer.
-
Lisa J. McReynolds Becomes the First Assistant Clinical Investigator of DCEG
In July 2019, Lisa J. McReynolds was appointed the first Assistant Clinical Investigator in the Clinical Genetics Branch.
-
Area Students Learn from DCEG Volunteers at NIH High School Scientific Training and Enrichment Program
Students in the 2019 NIH High School Scientific Training and Enrichment Program (HiSTEP) learned about the influence of technology on various groups and created public health campaign videos to educate target audiences about the risks and consequences of technology with the guidance of DCEG staff and fellows.
-
2019 Summer Intern Poster Event
The 2019 Summer Intern Program culminated in a poster session displaying students' research that took place on August 9, 2019.
-
Service and Science Recognized at NIH Director’s Awards
DCEG investigators received NIH Director’s Awards in July 2019 for their service to Camp Fantastic, the Agricultural Health Study, and the Women Scientist Advisors Executive Committee.
-
Hatch Retires from DCEG
Dr. Maureen Hatch, senior staff scientist in the Radiation Epidemiology Branch retired from DCEG in July 2019.
-
Validation of New High Throughput, Low Cost HPV Test for Cervical Cancer Prevention
High-throughput, low cost genotyping assay, TypeSeq, detects cervical precancer and estimates HPV vaccination efficacy.
-
Risk for Treatment-related Leukemia after Chemotherapy for Childhood Cancer has Increased Over Last 45 years
Risk of therapy-related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML) after initial chemotherapy for childhood cancer has significantly increased between 1975 and 2015, according to a new analysis by Pragati Advani, Ph.D., and colleagues.
-
MGUS Immune Markers Predict Risk of Progression to Multiple Myeloma
Longitudinal prospective study links changes in monoclonal gammopathy of undetermined significance (MGUS) immune markers with progression to multiple myeloma.
-
Breastfeeding Associated with Lower Breast Cancer Risk in Women with Li-Fraumeni Syndrome
Breastfeeding for at least seven months was associated with 43 percent reduced risk of breast cancer in women with the cancer predisposition syndrome, Li-Fraumeni Syndrome (LFS).